ArticleInflammatory intestinal diseases2021

Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany.

Niels Teich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.